Dual effect of glucose on LDL oxidation: Dependence on vitamin E

Free Radical Biology and Medicine

Volumn 33, Issue 8, 2002, Pages 1133-1140

  Otero, Paola ^a   Herrera, Emilio ^b   Bonet, Bartolomé ^b,c  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Free radicals; Glucose; Low density lipoprotein; Vitamin E

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; COPPER CHLORIDE; GLUCOSE; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; LIPID OXIDATION; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIOXIDANTS; ARTERIOSCLEROSIS; COPPER; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 0037108118     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01002-X     Document Type: Article

References (42)

1. Krolewski A.S., Warram J.H., Rand L.I., Kahn C.R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N. Engl. J. Med. 317:1987;1390-1398.
2. Krolewski A.S., Kosinski E.J., Warram J.H., Leland O.S., Busick E.J., Asmal A.C., Rand L.I., Christlieb A.R., Bradley R.F., Kahn C.R. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am. J. Cardiol. 59:1987;750-755.
3. Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
4. Reichard P., Nilsson B.-Y., Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Engl. J. Med. 329:1993;304-309.
5. Amthor K.F., Dahl-Jorgensen K., Berg T.J., Heier M.S., Sandvik L., Aagenaes O., Hanssen K.F. The effect of 8 years of strict glycemic control on peripheral nerve function in IDDM patients the Oslo study . Diabetologia. 37:1994;579-584.
6. Carew T.E. Role of biologically modified low-density lipoprotein in atherosclerosis. Am. J. Cardiol. 64:1989;18G-22G.
7. Steinbrecher U.P., Zhang H., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 9:1990;155-168.
8. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of Low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
9. Yla-Herttuala S. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann. Med. 23:1991;561-569.
10. Sato H., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., Yagi K. Lipid peroxides levels in plasma of diabetic patients. Chem. Med. 21:1979;104-107.
11. Tsai E.C., Hirsch I.B., Brunzell J.D., Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 43:1994;1010-1014.
12. Bonet B., Knopp R.H. Accelerated LDL oxidation in diabetic gestation. 2nd International Graz Symposium on Gestational Diabetes, Graz. 1992.
13. Otero P., Herrera E., Bonet B. Factores aterogénicos en adolescentes con diabetes mellitus insulinodependiente. Ava. Diabetol. 13:1997;110-115.
14. Jain S.K., Levine S.N., Duett J., Hollier B. Reduced vitamin E and increased lipofucsin products in erythrocytes of diabetic rats. Diabetes. 40:1991;1241-1244.
15. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J. Clin. Invest. 94:1994;771-778.
16. Maziere C., Auclair M., Bose-Robert F., Leflon P., Maziere J.C. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett. 363:1995;277-279.
17. Schmidt A.M., Yan S.D., Wautier J.L., Stern D. Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84:1999;489-497.
18. Lopes-Virella M.F., Klein R.L., Lyons T.J., Stevenson H.C., Witztum J.L. Glycosylation of low density lipoprotein enhances cholesterol ester synthesis in human monocyte-derived macrophages. Diabetes. 37:1988;550-557.
19. Fu M.-X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thrope S.R., Baynes J.W. Glycation,glycoxidation and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes. 43:1994;676-683.
20. Lewis B., The hyperlipidaemias. Clinical and laboratory practices. 1976;Blackwell Scientific Publications, Philadelphia.
21. Wang J., Huan C.-J., Chow C.K. Red cell vitamin E and oxidative damage a dual role of reducing agents . Free Radic. Res. 24:1996;291-298.
22. Otero P., Viana M., Herrera E., Bonet B. Antioxidant and prooxidant effects of ascorbic acid, dehydroascorbic acid and flavonoids on LDL submitted to different degrees of oxidation. Free Radic. Res. 27:1997;619-626.
23. Ma Y.-S., Stone W.L., Le Clair I. The effects of vitamin C and urate on the oxidation kinetics of human low density lipoprotein. P.S.E B.M. 206:1994;53-59.
24. Stait S.E., Leake D.S. Ascorbic acid can either increase or decrease low density lipoprotein modification. FEBS Lett. 341:1994;263-267.
25. Wefers H., Sies H. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur. J. Biochem. 174:1988;353-357.
26. Rumsey S.C., Galeano N.F., Arad Y., Deckelbaum R.J. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J. Lipid Res. 33:1992;1551-1561.
27. Viana M., Barbas C., Bonet B., Bonet M.V., Castro M., Fraile V., Herrera E. In vitro effects of a flavonoid-rich extract on LDL oxidation. Atherosclerosis. 123:1996;83-91.
28. Esterbauer H., Dieber-Rothereder M., Striegl G., Waeg G. Role of vitamin E in preventing the oxidation of low density lipoprotein. Am. J. Clin. Nutr. 53:1991;3195-3215.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Yagi K. Assay for blood plasma or serum. Packer L., Oxygen radicals in biological systems. Methods enzymol. 1984;328-331 Academic Press, New York.
31. Esterbauer H., Strieg G., Publ H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. 6:1989;67-75.
32. Esterbauer H., Puhl H., Dieber-Rotheneder M., Waig G., Rabl H. Effects of antioxidants on oxidative modification of LDL. Ann. Med. 23:1991;273-281.
33. Mlakar A., Batna A., Dudda A., Spiteller G. Iron (II) ions induced oxidation of ascorbic acid and glucose. Free Radic. Res. 25:1996;525-539.
34. Hunt J.V., Smith C.C., Wolff S.P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes. 39:1990;1420-1424.
35. Halliwell B. Vitamin C antioxidant or pro-oxidant in vivo? Free Radic. Res. 25:1996;439-454.
36. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am. J. Clin. Nutr. 54:1991;1119S-1124S.
37. Kadiiska M.B., Hanna P.M., Hernandez L., Mason R.P. In vivo evidence of hydroxyl radical formation after acute copper and ascorbic acid intake. Electron Spin Resonance Spin-Trapping Investigation. Mol. Pharmacol. 42:1992;723-729.
38. Thornalley P.J., Stern A. The production of free radicals during the autoxidation of monosaccharides by buffer ions. Carbohydr. Res. 134:1984;191-204.
39. Srivastara S.K., Ansari N.H. Prevention of sugar induced cataractogenesis in rats by butylated hydroxytoluene. Diabetes. 37:1988;1505-1508.
40. Viana M., Herrera E., Bonet B. Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia. 39:1996;1041-1046.
41. Cameron N.E., Cotter M.A., Maxfield E.K. Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia. 36:1993;299-304.
42. Halliwell B. The antioxidant paradox. Lancet. 385:2000;1179-1180.